Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
Condition:   Coronary Artery Disease Interventions:   Drug: Rosuvastatin;   Drug: Colchicine Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2023 Category: Research Source Type: clinical trials